Changeflow GovPing Healthcare FDA Denies Citizen Petition FDA-2025-P-3263 fro...
Routine Notice Added Final

FDA Denies Citizen Petition FDA-2025-P-3263 from George W. Murgatroyd III

Email

Summary

FDA CDER issued a final response letter denying citizen petition FDA-2025-P-3263 submitted by George W. Murgatroyd III. The petition was denied by the Center for Drug Evaluation and Research. No additional details are available as the document attachments contain personally identifiable information and are not publicly accessible.

Published by FDA CDER on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

FDA CDER issued a final response letter denying a citizen petition filed by George W. Murgatroyd III under Docket No. FDA-2025-P-3263. The petition denial represents the agency's final administrative determination. Affected parties seeking further recourse may need to pursue judicial review options.

Pharmaceutical companies and drug manufacturers involved in citizen petition processes should note this denial. Petition denials do not create new regulatory obligations but indicate FDA's position on the specific request made in the petition.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 2

Final Response Letter from FDA CDER to George W. Murgatroyd III

Restricted: Personally Identifiable Information

More Information
- Author(s) CDER

Final Response Letter from FDA CDER to George W. Murgatroyd III - Redacted

More Information
- Author(s) CDER
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA CDER.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA CDER
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2025-P-3263-0041
Docket
FDA-2025-P-3263

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug regulation Citizen petitions Regulatory responses
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Regulatory Affairs

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!